• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Virol . N-glycosylation at the receptor binding site drives differences in receptor binding specificity between influenza B virus lineages

tetano

Editor, Senior Moderator
J Virol


. 2025 Nov 5:e0103925.
doi: 10.1128/jvi.01039-25. Online ahead of print. N-glycosylation at the receptor binding site drives differences in receptor binding specificity between influenza B virus lineages

Caroline K Page[SUP] #[/SUP][SUP] 1 2 3 [/SUP], M H M Mubassir[SUP] #[/SUP][SUP] 2 4 [/SUP], Pradeep Chopra[SUP] 2 5 [/SUP], Lindsey Claire Gay[SUP] 1 6 [/SUP], Ginger Geiger[SUP] 1 2 [/SUP], Sean D Ray[SUP] 1 2 3 [/SUP], Justin D Shepard[SUP] 1 2 3 [/SUP], Rose J Miller[SUP] 1 2 3 [/SUP], Daniel Perez[SUP] 1 6 [/SUP], Justin Bahl[SUP] 2 3 4 7 [/SUP], Gerardus Josephus Boons[SUP] 2 5 8 9 [/SUP], Stephen Mark Tompkins[SUP] 1 2 3 [/SUP]



Affiliations
Abstract

Receptor specificity plays a critical role in influenza virus host tropism and pathogenesis. Influenza A and influenza B viruses (FLUAVs and FLUBVs, respectively) utilize N-glycans with terminal sialic acids on glycoproteins decorating the surface of mucosal epithelial cells as receptors for the virus hemagglutinin (HA) protein. For FLUAVs, the specificity of HA binding to distinct sialic acid linkages on host glycans is a major determinant of species specificity. Amino acid motifs and N-linked glycosylation sites influencing FLUAV HA receptor specificity are well defined. In contrast, considerably less is known regarding determinants of FLUBV receptor specificity, despite its significant contribution to the global influenza disease burden and unique restriction for human hosts. To address this knowledge gap, we utilize microarrays populated with glycans resembling structures found in the respiratory tract to comprehensively define the receptor binding profiles of FLUBVs from different decades and lineages and confirm these results with complementary virus-glycan binding assays. Using wild-type and reverse genetics FLUBVs having singular mutations in the HA receptor binding site (RBS), as well as structural models, we identify an N-glycosylation site at amino acid 196 within the RBS that determines the breadth of HA binding to terminal sialic acids. The definition of the presence of an N-linked glycan as the primary determinant for FLUBV receptor specificity provides a clear mechanism for lineage-specific differences in HA receptor binding. This may help explain the distinct tropism observed between Victoria and Yamagata lineage FLUBVs and provide insights into the disappearance of the Yamagata lineage.IMPORTANCEInfluenza B viruses (FLUBVs) are a major cause of human respiratory disease, but the molecular determinants influencing receptor specificity for the hemagglutinin protein remain largely undefined. We defined the receptor specificity of a panel of Early, Victoria, and Yamagata lineage viruses spanning over 50 years and showed that Victoria lineage viruses can have expanded receptor specificity, compared to Yamagata lineage viruses. We identified a critical N-glycosylation site within the hemagglutinin that regulates hemagglutinin binding to sialic acid receptors on host cells. Recent successful subclades of the Victoria lineage viruses lost this glycosylation site, enabling binding to both human-type and avian-type sialic acid receptors, which may influence respiratory tract tropism. These viruses also showed increased endemic activity. The expanded receptor tropism of Victoria lineage viruses may have fitness benefits, helping to explain epidemiologic features of the lineage, perhaps contributing to the lineage's recent success, while the Yamagata lineage appears to have become extinct.

Keywords: FLUBV; Victoria; Yamagata; glycosylation; influenza; receptor specificity.

 
Back
Top